Nanotechnology Now - Press Release: "Applied Nanoscience Comments on Trading Activity and Share Volume"

Home > Press > Applied Nanoscience Comments on Trading Activity and Share Volume

Abstract:
Applied Nanoscience Inc. (ANI) (PINKSHEETS: APNN), a nanotechnology-based filtration development company, today commented that the unusually heavy share volume and active trading in its stock yesterday is likely tied to the current swine flu outbreak. More specifically, the potential applicability of the company's core technology, NanoFense™, a proprietary antimicrobial nanoparticle formulation developed by ANI to coat or impregnate virtually any air filter media could be viewed as an advantageous product enhancement by air filtration companies.

Applied Nanoscience Comments on Trading Activity and Share Volume

CARLSBAD, CA | Posted on April 28th, 2009

ANI's NanoFense formulation has already been validated at well-known BSL-3 laboratories to be highly effective against the avian influenza simulant strain H9N2, the Human Influenza A virus as well as Haemophilus influenzae (H-flu). According to an independent virologist familiar with the technology and past testing, it is highly probable that the NanoFense formulation will be similarly effective against the current swine influenza strain A/H1N1.

####

About Applied Nanoscience Inc.
ANI is a marketer and developer of innovative, high performance nanotechnology-based filtration products to customers worldwide and is the owner of NEFT™ (Nanoparticle - Enhanced - Filtration - Technology), a broad platform with significant application potential in consumer market segments.

Safe Harbor Statement

This release may contain statements that are forward-looking. Such statements are made based upon current expectations that are subject to risk and uncertainty. ANI does not undertake to update forward-looking statements in this news release to reflect actual results of and changes in assumptions or changes in other factors affecting such forward-looking information. The actual future plans and results of the company could differ significantly from such forward-looking statements.

For more information, please click here

Contacts:
Philippe Niemetz
800-477-7570 or 212-344-6464

Investor Relations
PAN Consultants Ltd.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: